Skip to main content
Virulence logoLink to Virulence
editorial
. 2013 Sep 17;4(7):583–588. doi: 10.4161/viru.26360

Avian influenza virus NS1

A small protein with diverse and versatile functions

E M Abdelwhab 1,*, Jutta Veits 1, Thomas C Mettenleiter 1
PMCID: PMC3906290  PMID: 24051601

Avian influenza viruses (AIV) of H5N1 and H9N2 subtypes have zoonotic and pandemic potential. 377 out of 633 human infections with H5N1 virus were fatal and human infections by H9N2 virus were infrequently reported to the World Health Organization.1,2 Some H9N2 viruses either possessed genes similar to the H5N1 virus3,4 or were claimed to donate gene segments to H5N1 virus.5 Both features were reported in the Pakistani H9N2 viruses that have been recorded to be genetically similar to H5N1 isolated in Hong Kong in 19976 and also pertained a gene segment encoding the non-structural proteins (NS) almost identical to the co-circulating H5N1.7,8 Therefore, it is important to compare biologically the impact of NS1 protein on replication and within-host cell dynamics of H5N1 and H9N2 viruses which have been recently studied by Munir and coworkers8 and published in this issue of Virulence.

NS1: Is it More Vulnerable to Reassert than Other AIV Gene Segments?

The genome of AIV contains eight gene segments; polymerase basic 2 (PB2, segment 1), hemagglutinin (HA, segment 4), nucleoprotein (NP, segment 5) and neuraminidase (NA, segment 6) encode only one protein, whereas the PB1 (segment 2), polymerase acidic (PA, segment 3), the matrix (M, segment 7), and NS (segment 8) encode two proteins PB1 and PB1-F2, PA and PA-X, M1 and M2, and NS1 and NS2, respectively. Co-infection of the host cell with two or more AIV subtypes results in an exchange of gene segments designated as “reassortment” resulting in the emergence of novel viruses which may differ from their parent viruses in their ability to replicate and transmit between animals and humans.9 Reassortment is a well-known genetic trait of influenza viruses resulting in new viruses causing pandemics in 1918, 1957, 1968, and 2009. In these events, the pandemic viruses contained genes from influenza viruses of swine and/or avian origin.10

There are cumulative data on the reassortment of NS gene segments between different AIV, particularly the H5N1 subtype. In their recent study, Munir et al.8 raised this question again by reporting an H9N2 from backyard birds in Pakistan that carries the NS segment of H5N1 virus. Reassortment of the NS gene segment was observed within different clades of H5N1 in Hong Kong in 2000,11 Thailand in 2004–2008,12 Nigeria in 2006–2007,13 and Vietnam in 2010–2012.14 Intriguingly, three AIV subtypes, namely H1N1, H5N1, and H5N3, isolated from wild mallards in Belgium in 2008 had identical NS gene segments.15 Similarly, A/turkey/Ontario/7732/1966 (H5N9) acquired its NS gene from a contemporary H5N1 virus,16 and H6N2 and H6N8 from ostrich in South Africa acquired their NS genes from an H9N2 virus which was also closely related to contemporary H5N1 viruses in Asia.17,18 Although rare, reassortment of NS from different H9N2 clades was also reported in China in 2002.19 Moreover, NS of avian origin was introduced into swine influenza H1N1, H1N2, and H3N220 and equine H7N3 after 1973 as well as H3N8.21 Whether variations in the frequency of reassortment exist in influenza genome segments, particularly NS of the H5N1 virus merits in-depth investigation.

NS: The Smallest Influenza Gene Segment with Multiple, Sometimes Overlapping, Functional Domains

The NS segment is the smallest AIV gene segment encompassing about 890 nucleotides. The NS1 protein of AIV contains between 124 and 237 amino acids, but the vast majority specifies 230 amino acids.22 In H5N1 viruses deletion within the NS1 protein was observed between aa positions 80–84 and frequently in the tail region, mostly residues 225 to 230.23 On the other hand, NS1 of H9N2 contains almost 230 amino acids24 with rare insertion or deletion. Two genetic alleles (groups) of NS1 of more than 30% diversity were described. Allele A represents viruses of avian and mammalian origins, and allele B mainly avian origin viruses.21,22,25 Generally, allele A is more common than allele B.25,26 Identity between the NS1 proteins of H9N2 and H5N1 subtypes was more than 88%.24 In their study, Munir et al.8 reported almost identical NS1 genes of H9N2 and H5N1 viruses each with a total length of 225 amino acids due to deletion of the 80TMASV84 motif.

Structurally, the NS1 protein is composed of two functional domains, an RNA binding domain (RBD) and an effector domain (ED). The RBD is located within amino acids 1 to 73. It contains a nuclear localization signal (NLS1) and a poly(A)-binding protein site (PABPI). Thus, it binds to different RNA species (e.g., viral RNA, viral mRNAs, poly[A] RNA and double stranded RNA). The ED within amino acids 74 to 230 has specific regions to interact with several host factors and proteins (Table 1) including the cleavage and polyadenylation specificity factor 30 (CPSF30), eukaryotic translation initiation factor 4GI (eIF4GI), PABPII, p58b-subunit of phosphatidylinositol 3-kinase (P13K). In some viruses a second NLS and nucleolus localization signal (NoLS) exist.27-30

Table 1. Molecular anatomy of influenza virus NS1 protein.

Position Structure References
1–73 RNA binding domain 27
74–230/237 Effector domain 27
35–38 Nuclear localization signal 1 (NLS1) 85
35, 38, and 41 Nuclear localization signal 1 (NLS1) 86
38 and 41 RNA binding motifs 87
38 and 41 RNA helicase binding sites of the retinoic acid-inducible gene I (RIG-I) 62
1–81 Poly(A) binding protein I (PABPI) binding domain 27
81–113 Eukaryotic translation initiation factor 4GI (eIF4GI) binding domain 30
89 and 93 p85b binding domain 66 and 88
103 and 106 Cleavage and polyadenylation-specific factor 30-kDa subunit (CPSF30) binding domain 36
159 and 162 p85b binding domain 64
186 Cleavage and polyadenylation-specific factor 30-kDa subunit (CPSF30) binding domain 27
191–195 Cleavage and polyadenylation-specific factor 30-kDa subunit (CPSF30) binding domain 37
73–237 Staufen protein binding domain 27
123–127 Protein kinase R (PKR) binding domain 52
138–147 Nuclear export signal (NES) 86
148, 152, and 153 Nuclear export signal (NES) 31
164–167 A putative SH3 binding motif 64
207–212 Phosphatidylinositol 3-kinase (P13K) binding domain 65
212–215 A putative SH3 binding motif 64
218–232 Poly(A) binding protein II (PABPII) binding domain 62
219, 220, 231, and 232 Nuclear localization signal 2 (NLS2) 86
221 Nuclear localization signal 2 (NLS2) 31
221 Nucleolus localization signal (NoLS) 31
219, 220, 224, 229, 231, 232 Nucleolus localization signal (NoLS) 86
227–230 Postsynaptic density protein 95, Drosophila disc large tumor suppressor, and zonula occludens 1 protein (PDZ) binding domain 45

As a non-structural protein, NS1 is not present in virions but it is abundant in the nucleus of influenza virus-infected cells early during infection and also in the cytoplasm at later stages of the viral replication cycle.30 In their publication, Munir et al.8 showed that both NS1 proteins they studied localized primarily in the nucleus 24 h after transfection of human A549 cells. It is worth mentioning that both NS1 proteins studied by Munir et al.8 had an amino acid difference in position 221 that was described as essential for the nuclear and nucleolus localization of the protein.31

NS1: Enhancement of Virus Replication

Enhancement of viral replication by NS1 protein is usually achieved by direct activation of mRNA translation through interactions with, for example, eIF4GI and PABPII.32 Mutations or deletions in these domains significantly hampered replication of influenza viruses, both in vitro and in vivo33-35 due to an increased interferon (IFN) response and rapid elimination of the virus. Mutations at residues 103 and 106 of NS1 increased virus replication in tissue culture,33,36 and deletion of amino acids 191 to 195 reduced the ability of the virus to antagonize IFN production in chicken embryo fibroblast cells.37 Introduction of NS1 from an H5N1 into H7N1 altered host range and tissue tropism, increased suppression of the host immune response and influenced virus replication in cell culture.35,38,39 In contrast, NS1 reassortant viruses of H5N1 subtypes did not result in alteration of replication, tropism or pathogenicity of the viruses in experimentally infected ducks.40 Munir and coworkers8 showed in their study that both NS1 proteins, due to their high genetic relatedness, did not differentially affect transfection of H5N1 or H9N2 in different cell cultures.

NS1: A Virulence Marker

Virulence of influenza viruses is a multigenic trait, where mutations in more than one gene may be required to modulate severity of the disease in a host. NS1, in addition to other genes, was identified as a virulence determinant of the Spanish pandemic H1N1 from 1918–1919.41,42 H5N1 virus that had a D92E mutation or a deletion of residues 80–84 exhibited high virulence in chickens and mice.23 Mutations at residues 103 and 106 probably destabilize the CPSF30 binding pocket of NS1, and in an H5N1 or H1N1 enhanced virulence and altered brain-lung tropism in mouse model.33,36 Deletion of amino acids 191 to 195, corresponding to the CPSF30 binding domain, attenuated swine-origin H5N1 virus in chickens.37 Introduction of NS1 from an H5N1 into H7N1 increased virulence in mice and chicken embryos.35,38,39 Moreover, a sequence motif at the C-terminal end of NS1, “ESEV” or “EPEV” in AIV or “RSKV” or “RSEV”, in human H5N1 influenza viruses, in addition to interaction with PDZ-domain (postsynaptic density protein 95, Drosophila disc large tumor suppressor, and zonula occludens 1 protein) involved in cellular signal transduction pathways, was considered a species-specific virulence marker.43-45 The studies conducted by Munir and coworkers7,8 indicated that the NS1 of the two Pakistani H5N1 and H9N2 viruses had infrequent “ESKV” C-terminal PDZ motif with no clear effect on the pathogenicity after intravenous injection of 6-week-old chickens. Recently, highly pathogenic (HP) AIV H5N1 encoding NS1-ESKV in conjunction with NS1-F138Y caused local infection in mice respiratory tract, with mutations in both sites increasing virulence and resulting in systemic infection.46

NS1: A Host Range Determinant

Although species-specificity of the NS1 gene segment was reported earlier, the NS gene may not play an important role for host range restriction.21 There was no association between a gull-specific NS1 lineage and HA gene which may indicate compatibility of gull-specific NS with HA of different AIV. In contrast, host restricted genetic signatures were reported frequently from the NS1 genes of H13 and H16 AIV subtypes.47 HPAIV H7N1 containing NS1 from HPAIV H5N1 replicated at lower level in tracheal organ culture of chickens and turkeys,35 and changed the replication dynamic and the host cell responses in mammalian cells38 assuming host-specific variations. Among other proteins, concurrent mutations in the NS1 of an H9N2 were observed during adaptation to mice.48 Moreover, AIVs that harbor allele B replicate poorly in the respiratory epithelial cells of primates25,26 and efficiently on duck cells; conversely, the A allele is advantageous for replication in cells from chickens and turkeys origin.49 Human influenza viruses, except the pandemic H1N1 viruses in 1918–1919 and 2009, mostly encode NS1 proteins with T215 but AIV, including H5N1 viruses, encode P215.50 The PDZ domain 227–230 motif as described above also represents a species-specific genetic marker.43 In the current study, Munir and co-authors8 found that both NS1s, belonging to the A allele, supported growth of the viruses on chicken embryo fibroblasts (CEF) as well as on A549 cells.

NS1: A Multifaceted Regulatory Protein

The NS1 protein interacts with viral and cellular proteins. Preferential interaction of NS with the viral ribonucleoprotein complex,51 polymerase,52 NP, and/or M proteins53 is required for regulation of influenza virus replication. Also, associations of polymerase and NS1 mutations or NS1 and HA mutations play an essential role in pathogenicity of H5N1 in mammals.54,55 Therefore, the compatibility of NS1 to support replication of two different viruses, H9N2 belonging to the G1-lineage and H5N1 belonging to Z-genotype clade 2.2, as reported by Munir and colleagues,8 emphasizes the role of NS to generate diverse influenza viruses/variants with efficient replication in nature.

On the other hand, the main role of NS1 is to antagonize IFN which is accomplished through two pathways (reviewed in details in refs. 27 and 28). One mode is via binding different RNAs, particularly double stranded RNA, and subsequent inhibition of the pre-transcription pathway for activation of IFN due to inactivation of cellular sensors such as protein kinase R “PKR”56, retinoic-acid inducible gene I “RIG-I”57-59 and 2′-5′ oligoadenylate synthetase-RNase “2′-5′ OAS”60. The second mode is via interaction with a variety of IFN-induced cellular proteins/factors by specific, sometimes overlapping, regions (Table 1). Post-transcriptional inhibition of IFN production occurs via binding of the NS1 with CPSF30 and PABPII required for maturation and export of host mRNAs encoding antiviral proteins, including IFN mRNAs.58 Moreover, NS1 protein blocks induction of IFN by inactivation of TNF-α induced nuclear factor kappa B (NFκB), dsRNA-induced activator protein 1 (AP1), and the transcription factor IRF-3,41,61,62 and regulates the IFN-inducible genes (e.g., Myxovirus-resistance protein, interleukin-6).27,28 Also, NS1 protein enhances the translation of viral mRNA through interaction with eIF4GI and PABPI.63 It also binds a number of PDZ proteins.45 Furthermore, activation of the PI3K/Akt-pathway, including binding to SH3 and/or p85b, by NS1 protein to control apoptosis of the cells has been described.46,64-66 In late stages of the viral replication-cycle, the NS1 protein may be indirectly involved in morphogenesis of the virus particles through binding the Staufen protein.67,68 In their study, Munir et al.8 investigated the effect of NS1 protein of both H5N1 and H9N2 viruses on the IFN-β production in human and avian cells. They found that both NS1 proteins inhibited the IFN production equally by inhibition of the transcription factors IRF3, AP-1, and NFκB, and downregulation of IFN transcription both at the pre-mRNA and mature-mRNA levels.

NS1: A Target for Vaccine and Antiviral Therapy

Several experimental studies have shown that attenuated vaccines based on alterations in NS1 are effective to control influenza A and B viruses in different hosts. Viruses expressing truncated, site-specifically altered or temperature-sensitive NS1, have been assessed as vaccines. These vaccines have been validated to prevent clinical disease and limit virus excretion in pigs,69 horses,70 mice,71-74 ferrets,34 macaques,75,76 and turkeys.77 In chickens, the truncation or absence of NS1 in inactivated vaccines not only afforded protection against viral infection, but also provided a tool to differentiate between infected and vaccinated birds (DIVA73,78,79,80) by detection of anti-NS1 antibodies. Nonetheless, most of these studies did not address the stability of the vaccine in a live vaccine format. Brahmakshatriya et al.81 showed that NS1 truncated attenuated live vaccine in chickens is not stable and can revert to a wild-type phenotype after only five passages. Also, NS1 becomes an attractive target for development of new influenza antiviral drugs,82 particularly the CPSF30 binding domain.83 Some herbal oils inhibited NS1 protein function and subsequently decreased H1N1 replication in Madin Darby canine kidney (MDCK) cells.84 On the other hand, cellular pathways, particularly those associated with NS1, assessed in similar studies to that of Munir et al.8 may be targeted as alternative strategy for developing universal antiviral drugs/vaccines against influenza virus.

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Glossary

Abbreviations:

2'-5′ OAS

2'-5′ oligoadenylate synthetase-RNase

AIV

avian influenza virus

AP1

activator protein 1

CEF

chicken embryo fibroblasts

CSPF30

the cleavage and polyadenylation specificity factor 30

DIVA

differentiating between infected and vaccinated animals

ED

effector domain

eIF4GI

eukaryotic translation initiation factor 4GI

HA

hemagglutinin

HP

highly pathogenic

IFN

interferon

IRF-3

interferon regulatory factor-3

M

matrix

MDCK

madin darby canine kidney

NA

neuraminidase

NFκB

nuclear factor kappa B

NLS

nuclear localization signal

NoLS

nucleolus localization signal

NP

nucleoprotein

NS

non-structure

P13K

Phosphatidylinositol 3-kinase

PA

polymerase acidic

PABP

poly(A)-binding protein

PB

polymerase basic

PDZ

postsynaptic density protein 95, drosophila disc large tumor suppressor, and zonula occludens 1 protein

PKR

protein kinase R

RBD

RNA binding domain

RIG-I

retinoic-acid inducible gene I

TNF-α

tumor necrosis factor alpha

Munir M, Zohari S, Iqbal M, Abbas M, Perez DR, Berg M. The non-structural (NS) gene segment of H9N2 influenza virus isolated from backyard poultry in Pakistan reveals strong genetic and functional similarities to the NS gene of highly pathogenic H5N1. Virulence. 2013;4:612–23. doi: 10.4161/viru.26055.

10.4161/viru.26360

Footnotes

References

  • 1.Kalthoff D, Globig A, Beer M. (Highly pathogenic) avian influenza as a zoonotic agent. Vet Microbiol. 2010;140:237–45. doi: 10.1016/j.vetmic.2009.08.022. [DOI] [PubMed] [Google Scholar]
  • 2.WHO. Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2013. Avilable online at: http://www.who.int/influenza/human_animal_interface/EN_GIP_20130604CumulativeNumberH5N1cases.pdf (Accessed 26.08.2013). 2013.
  • 3.Lin YP, Shaw M, Gregory V, Cameron K, Lim W, Klimov A, Subbarao K, Guan Y, Krauss S, Shortridge K, et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc Natl Acad Sci U S A. 2000;97:9654–8. doi: 10.1073/pnas.160270697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Guan Y, Shortridge KF, Krauss S, Chin PS, Dyrting KC, Ellis TM, Webster RG, Peiris M. H9N2 influenza viruses possessing H5N1-like internal genomes continue to circulate in poultry in southeastern China. J Virol. 2000;74:9372–80. doi: 10.1128/JVI.74.20.9372-9380.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Guan Y, Shortridge KF, Krauss S, Webster RG. Molecular characterization of H9N2 influenza viruses: were they the donors of the “internal” genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci U S A. 1999;96:9363–7. doi: 10.1073/pnas.96.16.9363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cameron KR, Gregory V, Banks J, Brown IH, Alexander DJ, Hay AJ, Lin YP. H9N2 subtype influenza A viruses in poultry in pakistan are closely related to the H9N2 viruses responsible for human infection in Hong Kong. Virology. 2000;278:36–41. doi: 10.1006/viro.2000.0585. [DOI] [PubMed] [Google Scholar]
  • 7.Iqbal M, Yaqub T, Reddy K, McCauley JW. Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses. PLoS One. 2009;4:e5788. doi: 10.1371/journal.pone.0005788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Munir M, Zohari S, Iqbal M, Abbas M, Perez DR, Berg M. The non-structural (NS) gene segment of H9N2 influenza virus isolated from backyard poultry in Pakistan reveals strong genetic and functional similarities to the NS gene of highly pathogenic H5N1. Virulence. 2013;4:612–23. doi: 10.4161/viru.26055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56:152–79. doi: 10.1128/mr.56.1.152-179.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Taubenberger JK, Morens DM. Influenza: the once and future pandemic. Public Health Rep. 2010;125(Suppl 3):16–26. [PMC free article] [PubMed] [Google Scholar]
  • 11.Guan Y, Peiris M, Kong KF, Dyrting KC, Ellis TM, Sit T, Zhang LJ, Shortridge KF. H5N1 influenza viruses isolated from geese in Southeastern China: evidence for genetic reassortment and interspecies transmission to ducks. Virology. 2002;292:16–23. doi: 10.1006/viro.2001.1207. [DOI] [PubMed] [Google Scholar]
  • 12.Amonsin A, Lapkuntod J, Suwannakarn K, Kitikoon P, Suradhat S, Tantilertcharoen R, Boonyapisitsopa S, Bunpapong N, Wongphatcharachai M, Wisedchanwet T, et al. Genetic characterization of 2008 reassortant influenza A virus (H5N1), Thailand. Virol J. 2010;7:233. doi: 10.1186/1743-422X-7-233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Owoade AA, Gerloff NA, Ducatez MF, Taiwo JO, Kremer JR, Muller CP. Replacement of sublineages of avian influenza (H5N1) by reassortments, sub-Saharan Africa. Emerg Infect Dis. 2008;14:1731–5. doi: 10.3201/eid1411.080555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Creanga A, Thi Nguyen D, Gerloff N, Thi Do H, Balish A, Dang Nguyen H, Jang Y, Thi Dam V, Thor S, Jones J, et al. Emergence of multiple clade 2.3.2.1 influenza A (H5N1) virus subgroups in Vietnam and detection of novel reassortants. Virology. 2013;444:12–20. doi: 10.1016/j.virol.2013.06.005. [DOI] [PubMed] [Google Scholar]
  • 15.Van Borm S, Vangeluwe D, Steensels M, Poncin O, van den Berg T, Lambrecht B. Genetic characterization of low pathogenic H5N1 and co-circulating avian influenza viruses in wild mallards (Anas platyrhynchos) in Belgium, 2008. Avian Pathol. 2011;40:613–28. doi: 10.1080/03079457.2011.621410. [DOI] [PubMed] [Google Scholar]
  • 16.Ping J, Selman M, Tyler S, Forbes N, Keleta L, Brown EG. Low-pathogenic avian influenza virus A/turkey/Ontario/6213/1966 (H5N1) is the progenitor of highly pathogenic A/turkey/Ontario/7732/1966 (H5N9) J Gen Virol. 2012;93:1649–57. doi: 10.1099/vir.0.042895-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Abolnik C, Bisschop S, Gerdes T, Olivier A, Horner R. Outbreaks of avian influenza H6N2 viruses in chickens arose by a reassortment of H6N8 and H9N2 ostrich viruses. Virus Genes. 2007;34:37–45. doi: 10.1007/s11262-006-0007-6. [DOI] [PubMed] [Google Scholar]
  • 18.Abolnik C, Bisschop SP, Gerdes GH, Olivier AJ, Horner RF. Phylogenetic analysis of low-pathogenicity avian influenza H6N2 viruses from chicken outbreaks (2001-2005) suggest that they are reassortants of historic ostrich low-pathogenicity avian influenza H9N2 and H6N8 viruses. Avian Dis. 2007;51(Suppl):279–84. doi: 10.1637/7551-033106R.1. [DOI] [PubMed] [Google Scholar]
  • 19.Wang S, Shi WM, Mweene A, Wei HL, Bai GR, Liu JH. Genetic analysis of the nonstructural (NS) genes of H9N2 chicken influenza viruses isolated in China during 1998-2002. Virus Genes. 2005;31:329–35. doi: 10.1007/s11262-005-3251-2. [DOI] [PubMed] [Google Scholar]
  • 20.Brown IH, Harris PA, McCauley JW, Alexander DJ. Multiple genetic reassortment of avian and human influenza A viruses in European pigs, resulting in the emergence of an H1N2 virus of novel genotype. J Gen Virol. 1998;79:2947–55. doi: 10.1099/0022-1317-79-12-2947. [DOI] [PubMed] [Google Scholar]
  • 21.Kawaoka Y, Gorman OT, Ito T, Wells K, Donis RO, Castrucci MR, Donatelli I, Webster RG. Influence of host species on the evolution of the nonstructural (NS) gene of influenza A viruses. Virus Res. 1998;55:143–56. doi: 10.1016/S0168-1702(98)00038-0. [DOI] [PubMed] [Google Scholar]
  • 22.Suarez DL, Perdue ML. Multiple alignment comparison of the non-structural genes of influenza A viruses. Virus Res. 1998;54:59–69. doi: 10.1016/S0168-1702(98)00011-2. [DOI] [PubMed] [Google Scholar]
  • 23.Long JX, Peng DX, Liu YL, Wu YT, Liu XF. Virulence of H5N1 avian influenza virus enhanced by a 15-nucleotide deletion in the viral nonstructural gene. Virus Genes. 2008;36:471–8. doi: 10.1007/s11262-007-0187-8. [DOI] [PubMed] [Google Scholar]
  • 24.Banet-Noach C, Panshin A, Golender N, Simanov L, Rozenblut E, Pokamunski S, Pirak M, Tendler Y, García M, Gelman B, et al. Genetic analysis of nonstructural genes (NS1 and NS2) of H9N2 and H5N1 viruses recently isolated in Israel. Virus Genes. 2007;34:157–68. doi: 10.1007/s11262-006-0057-9. [DOI] [PubMed] [Google Scholar]
  • 25.Lin YP, Shu LL, Wright S, Bean WJ, Sharp GB, Shortridge KF, Webster RG. Analysis of the influenza virus gene pool of avian species from southern China. Virology. 1994;198:557–66. doi: 10.1006/viro.1994.1067. [DOI] [PubMed] [Google Scholar]
  • 26.Treanor J, Kawaoka Y, Miller R, Webster RG, Murphy B. Nucleotide sequence of the avian influenza A/Mallard/NY/6750/78 virus polymerase genes. Virus Res. 1989;14:257–69. doi: 10.1016/0168-1702(89)90006-3. [DOI] [PubMed] [Google Scholar]
  • 27.Hale BG, Randall RE, Ortín J, Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol. 2008;89:2359–76. doi: 10.1099/vir.0.2008/004606-0. [DOI] [PubMed] [Google Scholar]
  • 28.Lin D, Lan J, Zhang Z. Structure and function of the NS1 protein of influenza A virus. Acta Biochim Biophys Sin (Shanghai) 2007;39:155–62. doi: 10.1111/j.1745-7270.2007.00263.x. [DOI] [PubMed] [Google Scholar]
  • 29.Volmer R, Mazel-Sanchez B, Volmer C, Soubies SM, Guérin JL. Nucleolar localization of influenza A NS1: striking differences between mammalian and avian cells. Virol J. 2010;7:63. doi: 10.1186/1743-422X-7-63. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Zhou H, Zhu J, Tu J, Zou W, Hu Y, Yu Z, Yin W, Li Y, Zhang A, Wu Y, et al. Effect on virulence and pathogenicity of H5N1 influenza A virus through truncations of NS1 eIF4GI binding domain. J Infect Dis. 2010;202:1338–46. doi: 10.1086/656536. [DOI] [PubMed] [Google Scholar]
  • 31.Han H, Cui ZQ, Wang W, Zhang ZP, Wei HP, Zhou YF, Zhang XE. New regulatory mechanisms for the intracellular localization and trafficking of influenza A virus NS1 protein revealed by comparative analysis of A/PR/8/34 and A/Sydney/5/97. J Gen Virol. 2010;91:2907–17. doi: 10.1099/vir.0.024943-0. [DOI] [PubMed] [Google Scholar]
  • 32.Hale BG, Knebel A, Botting CH, Galloway CS, Precious BL, Jackson D, Elliott RM, Randall RE. CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology. 2009;383:6–11. doi: 10.1016/j.virol.2008.10.002. [DOI] [PubMed] [Google Scholar]
  • 33.Dankar SK, Wang S, Ping J, Forbes NE, Keleta L, Li Y, Brown EG. Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence. Virol J. 2011;8:13. doi: 10.1186/1743-422X-8-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Shelton H, Smith M, Hartgroves L, Stilwell P, Roberts K, Johnson B, Barclay W. An influenza reassortant with polymerase of pH1N1 and NS gene of H3N2 influenza A virus is attenuated in vivo. J Gen Virol. 2012;93:998–1006. doi: 10.1099/vir.0.039701-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Petersen H, Wang Z, Lenz E, Pleschka S, Rautenschlein S. Reassortment of NS segments modifies highly pathogenic avian influenza virus interaction with avian hosts and host cells. J Virol. 2013;87:5362–71. doi: 10.1128/JVI.02969-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Spesock A, Malur M, Hossain MJ, Chen LM, Njaa BL, Davis CT, Lipatov AS, York IA, Krug RM, Donis RO. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J Virol. 2011;85:7048–58. doi: 10.1128/JVI.00417-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Zhu Q, Yang H, Chen W, Cao W, Zhong G, Jiao P, Deng G, Yu K, Yang C, Bu Z, et al. A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens. J Virol. 2008;82:220–8. doi: 10.1128/JVI.00978-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Wang Z, Robb NC, Lenz E, Wolff T, Fodor E, Pleschka S. NS reassortment of an H7-type highly pathogenic avian influenza virus affects its propagation by altering the regulation of viral RNA production and antiviral host response. J Virol. 2010;84:11323–35. doi: 10.1128/JVI.01034-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ma W, Brenner D, Wang Z, Dauber B, Ehrhardt C, Högner K, Herold S, Ludwig S, Wolff T, Yu K, et al. The NS segment of an H5N1 highly pathogenic avian influenza virus (HPAIV) is sufficient to alter replication efficiency, cell tropism, and host range of an H7N1 HPAIV. J Virol. 2010;84:2122–33. doi: 10.1128/JVI.01668-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Sarmento L, Wasilenko J, Pantin-Jackwood M. The effects of NS gene exchange on the pathogenicity of H5N1 HPAI viruses in ducks. Avian Dis. 2010;54(Suppl):532–7. doi: 10.1637/8917-050409-Reg.1. [DOI] [PubMed] [Google Scholar]
  • 41.Basler CF, Aguilar PV. Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. Antiviral Res. 2008;79:166–78. doi: 10.1016/j.antiviral.2008.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Klenk HD, Garten W, Matrosovich M. Molecular mechanisms of interspecies transmission and pathogenicity of influenza viruses: Lessons from the 2009 pandemic. Bioessays. 2011;33:180–8. doi: 10.1002/bies.201000118. [DOI] [PubMed] [Google Scholar]
  • 43.Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A. 2008;105:4381–6. doi: 10.1073/pnas.0800482105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Soubies SM, Volmer C, Croville G, Loupias J, Peralta B, Costes P, Lacroux C, Guérin JL, Volmer R. Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence. J Virol. 2010;84:6733–47. doi: 10.1128/JVI.02427-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, Beer M, Wolff T. Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. J Virol. 2010;84:10708–18. doi: 10.1128/JVI.00610-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Fan S, Macken CA, Li C, Ozawa M, Goto H, Iswahyudi NF, Nidom CA, Chen H, Neumann G, Kawaoka Y. Synergistic effect of the PDZ and p85β-binding domains of the NS1 protein on virulence of an avian H5N1 influenza A virus. J Virol. 2013;87:4861–71. doi: 10.1128/JVI.02608-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Tønnessen R, Hauge AG, Hansen EF, Rimstad E, Jonassen CM. Host restrictions of avian influenza viruses: in silico analysis of H13 and H16 specific signatures in the internal proteins. PLoS One. 2013;8:e63270. doi: 10.1371/journal.pone.0063270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Wu R, Zhang H, Yang K, Liang W, Xiong Z, Liu Z, Yang X, Shao H, Zheng X, Chen M, et al. Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice. Vet Microbiol. 2009;138:85–91. doi: 10.1016/j.vetmic.2009.03.010. [DOI] [PubMed] [Google Scholar]
  • 49.Adams S, Xing Z, Li J, Mendoza K, Perez D, Reed K, Cardona C. The effect of avian influenza virus NS1 allele on virus replication and innate gene expression in avian cells. Mol Immunol. 2013;56:358–68. doi: 10.1016/j.molimm.2013.05.236. [DOI] [PubMed] [Google Scholar]
  • 50.Hsiang TY, Zhou L, Krug RM. Roles of the phosphorylation of specific serines and threonines in the NS1 protein of human influenza A viruses. J Virol. 2012;86:10370–6. doi: 10.1128/JVI.00732-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Marión RM, Zürcher T, de la Luna S, Ortín J. Influenza virus NS1 protein interacts with viral transcription-replication complexes in vivo. J Gen Virol. 1997;78:2447–51. doi: 10.1099/0022-1317-78-10-2447. [DOI] [PubMed] [Google Scholar]
  • 52.Min JY, Li S, Sen GC, Krug RM. A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology. 2007;363:236–43. doi: 10.1016/j.virol.2007.01.038. [DOI] [PubMed] [Google Scholar]
  • 53.Chen LM, Davis CT, Zhou H, Cox NJ, Donis RO. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog. 2008;4:e1000072. doi: 10.1371/journal.ppat.1000072. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Lycett SJ, Ward MJ, Lewis FI, Poon AF, Kosakovsky Pond SL, Brown AJ. Detection of mammalian virulence determinants in highly pathogenic avian influenza H5N1 viruses: multivariate analysis of published data. J Virol. 2009;83:9901–10. doi: 10.1128/JVI.00608-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Imai H, Shinya K, Takano R, Kiso M, Muramoto Y, Sakabe S, Murakami S, Ito M, Yamada S, Le MT, et al. The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog. 2010;6:e1001106. doi: 10.1371/journal.ppat.1001106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol. 2000;74:6203–6. doi: 10.1128/JVI.74.13.6203-6206.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Guo Z, Chen LM, Zeng H, Gomez JA, Plowden J, Fujita T, Katz JM, Donis RO, Sambhara S. NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol. 2007;36:263–9. doi: 10.1165/rcmb.2006-0283RC. [DOI] [PubMed] [Google Scholar]
  • 58.Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villán E, García-Sastre A, Gack MU. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog. 2012;8:e1003059. doi: 10.1371/journal.ppat.1003059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, García-Sastre A. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe. 2009;5:439–49. doi: 10.1016/j.chom.2009.04.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Min JY, Krug RM. The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A. 2006;103:7100–5. doi: 10.1073/pnas.0602184103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Flory E, Kunz M, Scheller C, Jassoy C, Stauber R, Rapp UR, Ludwig S. Influenza virus-induced NF-kappaB-dependent gene expression is mediated by overexpression of viral proteins and involves oxidative radicals and activation of IkappaB kinase. J Biol Chem. 2000;275:8307–14. doi: 10.1074/jbc.275.12.8307. [DOI] [PubMed] [Google Scholar]
  • 62.Darapaneni V, Prabhaker VK, Kukol A. Large-scale analysis of influenza A virus sequences reveals potential drug target sites of non-structural proteins. J Gen Virol. 2009;90:2124–33. doi: 10.1099/vir.0.011270-0. [DOI] [PubMed] [Google Scholar]
  • 63.Burgui I, Aragón T, Ortín J, Nieto A. PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol. 2003;84:3263–74. doi: 10.1099/vir.0.19487-0. [DOI] [PubMed] [Google Scholar]
  • 64.Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y. SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. J Virol. 2007;81:12730–9. doi: 10.1128/JVI.01427-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Heikkinen LS, Kazlauskas A, Melén K, Wagner R, Ziegler T, Julkunen I, Saksela K. Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling. J Biol Chem. 2008;283:5719–27. doi: 10.1074/jbc.M707195200. [DOI] [PubMed] [Google Scholar]
  • 66.Hale BG, Batty IH, Downes CP, Randall RE. Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem. 2008;283:1372–80. doi: 10.1074/jbc.M708862200. [DOI] [PubMed] [Google Scholar]
  • 67.Garaigorta U, Falcón AM, Ortín J. Genetic analysis of influenza virus NS1 gene: a temperature-sensitive mutant shows defective formation of virus particles. J Virol. 2005;79:15246–57. doi: 10.1128/JVI.79.24.15246-15257.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Falcón AM, Fortes P, Marión RM, Beloso A, Ortín J. Interaction of influenza virus NS1 protein and the human homologue of Staufen in vivo and in vitro. Nucleic Acids Res. 1999;27:2241–7. doi: 10.1093/nar/27.11.2241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Richt JA, Lekcharoensuk P, Lager KM, Vincent AL, Loiacono CM, Janke BH, Wu WH, Yoon KJ, Webby RJ, Solórzano A, et al. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J Virol. 2006;80:11009–18. doi: 10.1128/JVI.00787-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D, Arkins S, García-Sastre A, Palese P. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet J. 2009;41:87–92. doi: 10.2746/042516408X371937. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Ferko B, Stasakova J, Romanova J, Kittel C, Sereinig S, Katinger H, Egorov A. Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol. 2004;78:13037–45. doi: 10.1128/JVI.78.23.13037-13045.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72.Falcón AM, Fernandez-Sesma A, Nakaya Y, Moran TM, Ortín J, García-Sastre A. Attenuation and immunogenicity in mice of temperature-sensitive influenza viruses expressing truncated NS1 proteins. J Gen Virol. 2005;86:2817–21. doi: 10.1099/vir.0.80991-0. [DOI] [PubMed] [Google Scholar]
  • 73.Steel J, Lowen AC, Pena L, Angel M, Solórzano A, Albrecht R, Perez DR, García-Sastre A, Palese P. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol. 2009;83:1742–53. doi: 10.1128/JVI.01920-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Krenn BM, Egorov A, Romanovskaya-Romanko E, Wolschek M, Nakowitsch S, Ruthsatz T, Kiefmann B, Morokutti A, Humer J, Geiler J, et al. Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS One. 2011;6:e18577. doi: 10.1371/journal.pone.0018577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Baskin CR, Bielefeldt-Ohmann H, García-Sastre A, Tumpey TM, Van Hoeven N, Carter VS, Thomas MJ, Proll S, Solórzano A, Billharz R, et al. Functional genomic and serological analysis of the protective immune response resulting from vaccination of macaques with an NS1-truncated influenza virus. J Virol. 2007;81:11817–27. doi: 10.1128/JVI.00590-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Romanova J, Krenn BM, Wolschek M, Ferko B, Romanovskaja-Romanko E, Morokutti A, Shurygina AP, Nakowitsch S, Ruthsatz T, Kiefmann B, et al. Preclinical evaluation of a replication-deficient intranasal DeltaNS1 H5N1 influenza vaccine. PLoS One. 2009;4:e5984. doi: 10.1371/journal.pone.0005984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Wang L, Qin Z, Pantin-Jackwood M, Faulkner O, Suarez DL, Garcia M, Lupiani B, Reddy SM, Saif YM, Lee CW. Development of DIVA (differentiation of infected from vaccinated animals) vaccines utilizing heterologous NA and NS1 protein strategies for the control of triple reassortant H3N2 influenza in turkeys. Vaccine. 2011;29:7966–74. doi: 10.1016/j.vaccine.2011.08.067. [DOI] [PubMed] [Google Scholar]
  • 78.Avellaneda G, Mundt E, Lee CW, Jadhao S, Suarez DL. Differentiation of infected and vaccinated animals (DIVA) using the NS1 protein of avian influenza virus. Avian Dis. 2010;54(Suppl):278–86. doi: 10.1637/8644-020409-Reg.1. [DOI] [PubMed] [Google Scholar]
  • 79.Takeyama N, Minari K, Kajihara M, Isoda N, Sakamoto R, Sasaki T, Kokumai N, Takikawa N, Shiraishi R, Mase M, et al. Detection of highly pathogenic avian influenza virus infection in vaccinated chicken flocks by monitoring antibodies against non-structural protein 1 (NS1) Vet Microbiol. 2011;147:283–91. doi: 10.1016/j.vetmic.2010.07.002. [DOI] [PubMed] [Google Scholar]
  • 80.Wang L, Suarez DL, Pantin-Jackwood M, Mibayashi M, García-Sastre A, Saif YM, Lee CW. Characterization of influenza virus variants with different sizes of the non-structural (NS) genes and their potential as a live influenza vaccine in poultry. Vaccine. 2008;26:3580–6. doi: 10.1016/j.vaccine.2008.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Brahmakshatriya VR, Lupiani B, Reddy SM. Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens. Vaccine. 2010;28:2388–96. doi: 10.1016/j.vaccine.2009.12.074. [DOI] [PubMed] [Google Scholar]
  • 82.Ortigoza MB, Dibben O, Maamary J, Martinez-Gil L, Leyva-Grado VH, Abreu P, Jr., Ayllon J, Palese P, Shaw ML. A novel small molecule inhibitor of influenza A viruses that targets polymerase function and indirectly induces interferon. PLoS Pathog. 2012;8:e1002668. doi: 10.1371/journal.ppat.1002668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Xia S, Robertus JD. X-ray structures of NS1 effector domain mutants. Arch Biochem Biophys. 2010;494:198–204. doi: 10.1016/j.abb.2009.12.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Wu S, Patel KB, Booth LJ, Metcalf JP, Lin HK, Wu W. Protective essential oil attenuates influenza virus infection: an in vitro study in MDCK cells. BMC Complement Altern Med. 2010;10:69. doi: 10.1186/1472-6882-10-69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Cauthen AN, Swayne DE, Schultz-Cherry S, Perdue ML, Suarez DL. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J Virol. 2000;74:6592–9. doi: 10.1128/JVI.74.14.6592-6599.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Keiner B, Maenz B, Wagner R, Cattoli G, Capua I, Klenk HD. Intracellular distribution of NS1 correlates with the infectivity and interferon antagonism of an avian influenza virus (H7N1) J Virol. 2010;84:11858–65. doi: 10.1128/JVI.01011-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Wang W, Riedel K, Lynch P, Chien CY, Montelione GT, Krug RM. RNA binding by the novel helical domain of the influenza virus NS1 protein requires its dimer structure and a small number of specific basic amino acids. RNA. 1999;5:195–205. doi: 10.1017/S1355838299981621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE. Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A. 2006;103:14194–9. doi: 10.1073/pnas.0606109103. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Virulence are provided here courtesy of Taylor & Francis

RESOURCES